Literature DB >> 6277464

Abnormal bone and parathyroid histology in carcinoma patients with pseudohyperparathyroidism.

C F Sharp, R K Rude, R Terry, F R Singer.   

Abstract

Postmortem bone and parathyroid gland histology in nine hypercalcemic cancer patients without bone metastases was compared to bone and parathyroid histology in ten normocalcemia patients. Parameters of parathyroid function, including serum immunoreactive parathyroid hormone, acid base status, serum phosphate, and nephrogenous cyclic AMP were measured in the hypercalcemic group and compared to normals and to patients with primary hyperparathyroidism. Bone histology in all nine hypercalcemic cancer patients showed increased osteoclastic bone resorption and increased fibrous connective tissue in the bone marrow. Parathyroid glands were of normal size in all nine patients but contained little or no fat, one criterion of parathyroid hyperplasia. In the normocalcemic cancer patients only 2/10 had minimally increased bone resorption while 7/10 had decreased or absent stromal fat in the parathyroid glands. Despite the hyperplastic appearance of the parathyroid glands, serum biochemical parameters in the hypercalcemic cancer patients indicate a state of suppressed parathyroid function suggesting that the osteoclastic bone resorption is related to a humoral substance elaborated by the tumors which is distinct from parathyroid hormone.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277464     DOI: 10.1002/1097-0142(19820401)49:7<1449::aid-cncr2820490723>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Synthetic human parathyroid hormone-like protein stimulates bone resorption and causes hypercalcemia in rats.

Authors:  A F Stewart; M Mangin; T Wu; D Goumas; K L Insogna; W J Burtis; A E Broadus
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

2.  Cis-platinum treatment for malignancy-associated humoral hypercalcemia in an athymic mouse model.

Authors:  L J Kukla; E C Abramson; W P McGuire; D H Shevrin; T Lad; S C Kukreja
Journal:  Calcif Tissue Int       Date:  1984-09       Impact factor: 4.333

3.  Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry.

Authors:  P D Delmas; B Demiaux; L Malaval; M C Chapuy; C Edouard; P J Meunier
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.